Skip to content
Search

Latest Stories

Boots expands Pharmacy Contraception Service to over 1,250 stores

Boots expands Pharmacy Contraception Service to over 1,250 stores

Expanding access to oral contraception through community pharmacies empowers women to make informed decisions about their reproductive health - says Boots pharmacist Claire Nevinson 

Boots has announced the rollout of the NHS Pharmacy Contraception Service in more than 1,250 stores across England.


This service offers patients a free, accessible, and convenient way to obtain regular oral contraception—either a progesterone-only pill or a combined pill—without the need to schedule a GP appointment.

Claire Nevinson, superintendent pharmacist at Boots, highlighted that expanding access to oral contraception through community pharmacies empowers women to “make informed decisions about their reproductive health.”

She added: “Many of our stores are open in the evenings and on weekends, when GPs are typically closed, so the service allows patients to access contraceptive support at a time that suits them.”

Andrew Hogan, a pharmacist providing the service at a Boot store in Durham, expressed his satisfaction in being able to support patients in new ways while also helping to reduce pressure on GP surgeries.

He shared: “Since launching the service in our store, I’ve been able to supply a number of patients with oral contraception.

“The feedback has been really positive so far and patients like the easy access to confidential consultations with a healthcare professional at a time that fits into women’s busy lives has been very well received.”

Boots noted that the service is available to patients from the onset of menstruation up to age 49 for combined oral contraception, and up to age 54 for the progesterone-only pill.

During a private consultation, a specially trained Boots pharmacist will conduct a health assessment and advise on the different contraception pill options that are suitable for the patient.

Following the consultation, the pharmacist can provide a new or repeat supply of contraception pill or refer the patient to a GP if a supply is not appropriate.

Starting in Spring 2023, pharmacies were permitted to register for the NHS Pharmacy Contraception advanced service, enabling them to offer ongoing supplies of oral contraception.

Beginning on 1 December 2023, the service expanded to allow individuals to have confidential consultations with community pharmacists to request a prescription for the contraceptive pill directly from their pharmacist instead of going through their GP or a sexual health clinic.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less